Why is it important?
In the context of evolving requirements across countries and markets, preparing for a successful HTA submission is essential. Securing a price and reimbursement that represents value to payers, physicians, patients, and the pharmaceutical company, requires the product’s value with respect to illness, treatment pathway, and clinical and economic evidence. The timing of this preparation is absolutely critical.
What we do at Creativ-Ceutical
Our Market Access and HTA teams have the expertise to develop Briefing Books for early scientific advice as well as high-quality and successful evidence-based Global Value Dossiers. Our consultants are dedicated to providing remarkable, unyielding customer support during their preparation of HTA Submission Dossiers to authorities.